Auriga Laboratories CEO Featured in Exclusive Interview With WallSt.net

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Argentvive.Assd	LSE:ARGA	London	Ordinary Share	GB00B1WST890	ORD 1P (ASSD CHARLES DENTON CASH)

Share Name

Share Symbol

Market

Type

Share ISIN

Share Description

Argentvive.Assd

LSE:ARGA

London

Ordinary Share

GB00B1WST890

ORD 1P (ASSD CHARLES DENTON CASH)

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

0.00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Industry Sector

Turnover

Profit

EPS - Basic

PE Ratio

Market Cap

N/A

Auriga Laboratories CEO Featured in Exclusive Interview With WallSt.net

21/08/2006 1:00pm

PR Newswire (US)

Argentvive.Assd (LSE:ARGA)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Argentvive.Assd Charts.

NEW YORK, Aug. 21 /PRNewswire/ -- On August 17, Philip S. Pesin, Chief Executive Officer for Auriga Laboratories(TM), Inc. (OTC:ARGA) (BULLETIN BOARD: ARGA) updated the investment community in an exclusive interview with http://www.wallst.net/ . Topics covered in the interview include an overview of the Company and the markets it serves, recent press releases, current capitalization, and upcoming strategic and financial milestones. To hear the interview in its entirety, visit http://www.wallst.net/ , and click on "Interviews." Interviews require free registration, and can be accessed either by locating the respective company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the respective company's ticker symbol in the Search Archive window. About Auriga Laboratories (TM): Auriga Laboratories(TM) is a specialty pharmaceutical company capitalizing on high-revenue markets and opportunities in the pharmaceutical industry through aggressive sales, integrated marketing and advanced in-house drug development capabilities. The Company's high-growth business model combines acquisition of proven brand names, powerful product development strategies and rapidly-growing national sales teams and marketing operations. Auriga acquires valuable brand portfolios that are no longer a strategic focus for large pharmaceutical companies, then capitalizes on untapped marketplace opportunities through brand extension and directed sales/marketing programs. The Company's drug-development pipeline leverages novel material science and advanced drug delivery technologies to produce improved formulations of successful drug portfolio brands to further expand markets, sales and clinical indications for proven, successful products. Auriga plans to become a fully integrated pharmaceutical company by acquiring its own manufacturing and development capabilities. For more information, please visit: http://www.aurigalabs.com/ . About WallSt.net: http://www.wallst.net/ is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The website is a leading provider of financial news, media, tools and community-driven applications for investors. http://www.wallst.net/ offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies. We are expecting to receive one hundred seventy five dollars from Auriga Laboratories(TM), Inc. for the dissemination of this press release. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp . DATASOURCE: WallStreet Direct, Inc. CONTACT: Nick Iyer of Digital Wall Street, Inc., +1-800-4-WALL-ST Web site: http://www.wallst.net/ http://www.aurigalabs.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ARGA Argentvive.Assd